ROCKVILLE, MD: The Agency for Healthcare Research and Quality awarded Ogilvy PR Worldwide two contracts. The bulk of both are funded by the Recovery Act and could be worth up to $41 million over three years.
The contracts provide communications support for the healthcare agency's comparative effectiveness research.
The American Recovery and Reinvestment Act allots $1.1 billion for comparative effectiveness research, which aims to compare medical treatments and determine the benefits and harms, improve care, and reduce costs.
The goal of the contracts “is to ...